Interferon Production by Human-Mouse Hybrid Cells: Dominant Mouse Control of Superinduction and Priming
(Accepted 2 November I979) SUMMARY We have examined the production of interferon by a number of human-mouse hybrid clones in response to polyriboinosinic acid:polyribocytidylic acid copolymer [poly(rI).poly(rC)], all of which produced both human and mouse interferons when stimulated with a virus. Their capacity to be superinduced and primed for interferon production in response to poly(rI).poly(rC) was compared to that of the parental human and mouse cells. It was found that the hybrids responded in a way similar to their mouse cell parents, indicating dominant mouse control of both the priming and superinduction phenomena.
Interferon yields may be significantly increased if mammalian cell lines are treated with homologous interferon (priming) before induction with a virus or poly(rI).poly(rC) (Isaacs & Burke, I958; Friedman, I966; Levy et al. 1966; Rosztoczy & Mecs, I97o; Stewart et al. 1971 ; Billiau et al. 1972, I973) , or by the judicious additions of inhibitors of macromolecular biosynthesis during and after poly(rI).poly(rC) induction (superinduction; Tan et al. I97o; Vilcek, ~97o; Havell & Vilcek, 1972; Billiau et al. r973; Tan & Berthold, I977) . However, the responsiveness of human and rodent cells to priming and superinducing conditions varies considerably. For instance, human lymphocytes and lymphoblastoid cell lines fail to respond to poly(rI).poly(rC) induction (Tan et al. I974a; J. Morser, personal communication) and thus cannot be superinduced. Further, several human transformed and tumour-derived cell lines, which have lost contact inhibition, also do not superinduce and/or prime well (Billiau et al. ~977; D. C. Burke, G. Stein & A. Meager, unpublished results) . The capacity of human-mouse hybrids to be primed by human interferon will probably depend in the first instance on whether the hybrids retain the cell surface receptors to which human interferon binds to trigger the antiviral state in both human and human-mouse hybrids. These receptors have beert shown to be coded by a gene or genes on the long arm of human chromosome 2 ~ (Tan et aL I973, I974b; Tan, 1975; Chany et al. r975; Epstein & Epstein, 1976; Revel et al. I976; Tan & Greene, 1976) and it is known that this locus is asyntenic with the human interferon production loci (Tan et al. I974a; Morgan & Faik, I977) .
In a previous paper (Meager et al. I979a) we described several human-mouse cell hybrids which produced both human and mouse interferons. After analysing their karyotypes, chromosomal assignments were made for the locus governing the production of human interferon. In this paper we examine several human-mouse hybrids for interferon production after priming or superinduction in an attempt to resolve the question of whether human and mouse interferon production in hybrid cells are independently or co-ordinately activated by different induction schedules. We hoped that this study would also show which parental cell, mouse or human, had the dominant control of the interferon system in hybrids. The control mechanisms for the expression of human genes in a foreign cell environment, e.g. hybrid cell, are of broad interest, but are not well understood, and the study of the modulation of the human interferon gene in hybrid cells offers an opportunity for investigating these mechanisms. The cells and viruses used in this study have been described previously (Meager et al. ~979 a) . The CTP series of human-mouse hybrids had human T-lymphocytes as the human cell parent and the mouse PGI 9 cell line (Jonasson et al. I977) as mouse cell parent. The HL series of hybrids and human embryo fibrobtasts (HEF) and mouse LA9 cells as their respective human and mouse cell parents (Meager et al. I979a) .
Interferons were induced with Newcastle disease virus (NDV), strain Texas (5 to Ioo p.f.u./cell) as previously described (Meager et al. I979a) . In experiments in which priming was used, cell cultures were incubated for i6 h at 37 °C with the appropriate concentrations of mouse L cell interferon or human fibroblast interferon before induction with NDV or poly(rI), poly(rC). Confluent monolayer cultures were induced with poly(rI). poly(rC) at 50 or ~oo/~g/ml for I to 2 h at 37 °C in serum-free medium. They were then washed extensively with serum-free medium and finally incubated for 20 to 24 h at 37 °C in 2 to 4 ml of maintenance medium containing 2 % foetal bovine serum (Atherton & Burke, 2975) . The superinduction method, a modification of that of Tan & Berthold 0977), was as previously described by Meager et al. (I979b) . All interferon samples induced by poly(rl). poly(rC) were treated with RNase (pancreatic ribonuclease, 5 ° #g/ml plus ribonuclease T1, 300 units/ml) for I h at 37 °C before assay to eliminate any residual poly(rI).poly(rC).
Interferon assays were carried out as described by Meager et al. 0979a). Amounts are given in research reference units (U) based on the 69/I9 human leucocyte and the Goo2-9o2-oa6 mouse interferon standards. The sensitivity of a hybrid clone to human interferon was assessed in terms of the titre obtained with an interferon preparation obtained from human embryo fibroblasts (titre-4"I log10 U/ml) on the hybrid cells.
In order to find human-mouse cell hybrids capable of responding to human interferon, for use in subsequent priming experiments, 2o hybrids were screened. Several sensitive clones were found and all contained human chromosome 2I; all were much less sensitive than their parental human fibroblast line, possibly because they contain chromosome 2r in a monosomic state. Of the eight hybrid clones producing human interferon in response to NDV (Meager et al. I979a) , three clones (HLI5, HL35 and HL4z ) were also sensitive to human interferon, whereas the other five (HL2o, HL53, HL57, CTP34 and CTP4D were relatively insensitive. There were many other hybrid clones, e.g. HL8 and HL54 (Meager et al. I979a) which did not produce interferon but were sensitive to it. This shows that sensitivity to human interferon and ability to produce it are separately controlled, as already reported by Tan et al. (I974a) and Morgan & Faik (I977) .
The parental human (HEF) cell line and the parental mouse cell lines (PGI9 and LA 9) were induced to form interferon with poly(rI).poly(rC) at a concentration of 5o #g/ml which was found to be optimal. Results are shown in Table I as the number of units formed per ml per million cells. HEF cells produced 2oo to 4oo units of human interferon; PG~9 cells produced 13o units of mouse interferon but LA9 cells did not respond at all. Table I also shows the results obtained with a number of human-mouse cell hybrids stimulated with poly(rI).poly(rC) at the higher concentration of mo #g/ml. All of these had previously been shown (Meager et aL I979a) to produce both human and mouse interferon in response to NDV. Of all those tested, one hybrid (CTP34, tested between passages I8 and 2I) yielded small amounts of both human and mouse interferons. The same hybrid at passage 23 and another hybrid (CTP4~) produced only mouse interferon. Hybrids formed from human embryo fibroblasts and the mouse line LA 9 produced no human or mouse interferon. The superinduction procedure increased the yields of interferon from HEF and PGI 9 by an order of magnitude, but LA 9 cells still produced no mouse interferon (Table I ). The same procedure greatly increased the yields of mouse interferon from those hybrids which responded without superinduction, but had much less effect on human interferon production. CTP34 at passage I8 produced considerably more human interferon under superinduction conditions.
The parental cells and the hybrids were also stimulated with poly(rI).poly(rC) after pre-treatment (priming) with human interferon or mouse interferon. A concentration of 20o units/ml of human leucocyte or fibroblast interferon was found to be the optimum for priming HEF cells. Pre-treatment with mouse interferon did not prime PGI9 cells, but had a weak priming effect on LA 9 cells. Priming, whether with human or mouse interferon, had little effect on those hybrids tested, even though they were sensitive to the interferons.
Similar studies were carried out in cells induced with NDV, strain Texas, at 5 or 5o p.f.u./ cell and with different amounts of human or mouse interferon for priming. As shown in Table 2 , the parental human and mouse cells formed the corresponding interferon when stimulated with NDV. The hybrid clone, CTP34, produced only mouse interferon when treated with NDV at 5 p.f.u./cell, but produced more mouse interferon and some human interferon when stimulated with NDV at 50 p.f.u./cell.
Priming with increasing amounts of mouse interferon over the range t to I oo units/ml led to a progressive depression of interferon yields in response to NDV from the mouse cells, PG~ 9. This may reflect the antiviral effect of the interferon on the function or functions of the inducing virus which are required to elicit interferon formation (Margolis et al. 1972 ) . A similar effect was seen with the hybrid, CTP34, which has PGI 9 as the parental mouse cell. Unlike PGT 9 cells, mouse LA9 cells were primed slightly (but reproducibly in a number of experiments) by small amounts (e.g. I unit/ml) of mouse interferon. Priming with larger amounts of mouse interferon inhibited production. Similar results were obtained with hybrids with LA9 as the mouse cell parent and there were similar effects on the production of human interferon by those hybrids which formed any in response to NDV. When human fibroblast interferon was tested as a priming agent (Io units/ml were used because these hybrids are less sensitive to human interferon than the parental HEF), one hybrid (HL15, subclone 9) produced slightly more human and mouse interferon, while another (HE54) produced larger amounts of mouse interferon only. The slight increases in human interferon were reproducibly found and appear smaller than they actually were because yields are expressed per lO 6 cells (this normalization of the data allows comparisons between different experiments). The hybrid, HL53, which is insensitive to human interferon, did not respond when primed. A larger priming dose (ioo units/ml) of human fibroblast interferon inhibited interferon production by the sensitive hybrids.
Production of interferons in cell hybrids and parental cells in response to ND V Texas induction: effect of priming
The effects of superinduction and priming in our human-mouse cell hybrids support the idea that the interferon system is regulated by the dominant mouse control. This is not surprising since, in general, our hybrids retain a full complement of mouse chromosomes and only a small subset of human chromosomes (Meager et al. I979a) . They would therefore be expected to resemble the mouse parental cell phenotype more closely than the human one.
We have no evidence, so far, that production of mouse and human interferons are separately controlled in our hybrids. Both mouse and human interferons are induced by NDV (Meager et al. 1979 a) and in hybrids sensitive to poly(rI), poly(rC), e.g. CTP34, both species are also induced and superinduced. In contrast, Tan et al. (1974a) reported that their human-mouse hybrids with human lymphocyte parents were inducible for mouse and human interferons with NDV, but produced only human interferon in response to poly(rl). poly(rC). Slate & Ruddle 0979), using human-mouse hybrids with human fibroblast parents, have also recently published findings similar to those of Tan et al. 0974a ). At present, we have no explanation for this appparent difference between our hybrids and theirs. Nevertheless, results in agreement with our hypothesis that the interferon system is regulated by the dominant parental cell have been reported by Frankfort et aL (I978) for a single human-mouse hybrid, 55-91F2. This, however, segregated mouse chromosomes instead of human; its phenotype and interferon system presumably resembled that of the human cell parent, though no data were presented concerning the parental human ceils.
De Clercq et aL (I975) have claimed that the non-antiviral effects of human interferon, e.g. priming and inhibition of cell growth, are not mediated by the cell surface receptor specified by a gene(s) on chromosome 2t: human interferon interacts with the receptor to trigger the setting up of the antivirai state (Tan et aL I973, I974b; Chany et al. r975; Epstein & Epstein, 1976; Revel et aL ~976; Tan & Greene, I976) . Our results do not support this contention. Hybrids having chromosome 2I are in some instances, e.g. HLI5 SC9, primed by human interferon, whereas a hybrid lacking this chromosome, e.g. HL53 does not prime. Frankfort et al. (I978) also found that their human-mouse hybrid GM52xBalb V CII5, which contained chromosome 21, resembled our hybrid HL54 (Table 2 ) and was primed with human interferon to produce more mouse interferon. Cupples & Tan (I977) showed that Down's syndrome lymphocytes, which are trisomic for chromosome 2I, are more sensitive to the cell growth inhibition effect of interferon than are lymphocytes from normal diploid patients. Taken together, these results suggest that the receptor specified by chromosome 2I is common for all interferon-mediated effects.
